JP2005517643A5 - - Google Patents

Download PDF

Info

Publication number
JP2005517643A5
JP2005517643A5 JP2003549322A JP2003549322A JP2005517643A5 JP 2005517643 A5 JP2005517643 A5 JP 2005517643A5 JP 2003549322 A JP2003549322 A JP 2003549322A JP 2003549322 A JP2003549322 A JP 2003549322A JP 2005517643 A5 JP2005517643 A5 JP 2005517643A5
Authority
JP
Japan
Prior art keywords
alkyl
group
substituted
unsubstituted
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003549322A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005517643A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/036128 external-priority patent/WO2003048130A2/en
Publication of JP2005517643A publication Critical patent/JP2005517643A/ja
Publication of JP2005517643A5 publication Critical patent/JP2005517643A5/ja
Pending legal-status Critical Current

Links

JP2003549322A 2001-11-30 2002-11-26 ペルオキシソーム増殖因子活性化受容体アゴニスト Pending JP2005517643A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33445301P 2001-11-30 2001-11-30
PCT/US2002/036128 WO2003048130A2 (en) 2001-11-30 2002-11-26 Peroxisome proliferator activated receptor agonists

Publications (2)

Publication Number Publication Date
JP2005517643A JP2005517643A (ja) 2005-06-16
JP2005517643A5 true JP2005517643A5 (enExample) 2006-01-05

Family

ID=23307275

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003549322A Pending JP2005517643A (ja) 2001-11-30 2002-11-26 ペルオキシソーム増殖因子活性化受容体アゴニスト

Country Status (19)

Country Link
US (1) US7544812B2 (enExample)
EP (1) EP1453811A2 (enExample)
JP (1) JP2005517643A (enExample)
KR (1) KR20050044606A (enExample)
CN (1) CN1582279A (enExample)
AU (1) AU2002356927A1 (enExample)
BR (1) BR0214437A (enExample)
CA (1) CA2468846A1 (enExample)
CO (1) CO5640129A2 (enExample)
EA (1) EA007163B1 (enExample)
HR (1) HRP20040469A2 (enExample)
HU (1) HUP0402486A3 (enExample)
IL (1) IL161578A0 (enExample)
MX (1) MXPA04005123A (enExample)
NO (1) NO20042737L (enExample)
NZ (1) NZ532909A (enExample)
PL (1) PL370515A1 (enExample)
WO (1) WO2003048130A2 (enExample)
ZA (1) ZA200404173B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1662487A (zh) 2002-06-19 2005-08-31 伊莱利利公司 酰胺连接基过氧化物酶体增殖物激活受体调节剂
US7816385B2 (en) * 2002-12-20 2010-10-19 High Point Pharmaceuticals, Llc Dimeric dicarboxylic acid derivatives, their preparation and use
DE10351859A1 (de) * 2003-11-06 2005-06-09 Beiersdorf Ag Emulsionen mit zwei Verdickungsmitteln
US20080125403A1 (en) 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
US7456164B2 (en) 2004-05-07 2008-11-25 Pfizer, Inc 3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
WO2006036512A2 (en) * 2004-09-28 2006-04-06 Allergan, Inc. Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
CA2655574A1 (en) 2006-06-20 2007-12-27 Wyeth Imidazole kv1.5 potassium channel inhibitors
FR2903984B1 (fr) * 2006-07-24 2008-10-03 Genfit Sa Derives d'imidazolones substitues, preparation et utilisations
WO2008094860A2 (en) 2007-01-30 2008-08-07 Allergan, Inc. Treating ocular diseases using peroxisome proliferator-activated receptor delta antagonists
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
CN101875636B (zh) * 2010-05-18 2012-01-04 浙江大学 咪唑啉-2,4-二酮类衍生物及制备方法和用途
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
CN115894379B (zh) * 2022-01-20 2025-06-27 哈尔滨三联药业股份有限公司 海因类化合物及其医药用途
CN114835655A (zh) * 2022-04-14 2022-08-02 河南师范大学 一种合成光学活性三氟甲基丙烯酸酯类化合物的方法
LU605402B1 (en) * 2024-07-11 2026-07-14 Sea4Us Biotecnologia E Recursos Marinhos Sa Oxazolidone-derived compounds and their use in the treatment of chronic and acute pain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452041A (en) * 1965-05-19 1969-06-24 American Home Prod Hydantoin compounds and methods of preparation
HU183046B (en) 1976-06-03 1984-04-28 Wellcome Found Process for producing hydanthoine derivatives
GB1601310A (en) 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
JPS59159163A (ja) * 1983-03-01 1984-09-08 Fuji Photo Film Co Ltd ハロゲン化銀カラ−感光材料
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
PT966447E (pt) 1997-03-03 2003-07-31 Boehringer Ingelheim Pharma Moleculas pequenas uteis no tratamento de doencas inflamatorias
WO2001016120A1 (en) * 1999-08-27 2001-03-08 Eli Lilly And Company Biaryl-oxa(thia)zole derivatives and their use as ppars modulators

Similar Documents

Publication Publication Date Title
JP2005053931A5 (enExample)
JP2005523310A5 (enExample)
JP2007508359A5 (enExample)
JP2006524222A5 (enExample)
JP2005514366A5 (enExample)
JP2005507872A5 (enExample)
JP2008510828A5 (enExample)
JP2007524696A5 (enExample)
JP2005518357A5 (enExample)
JP2002520309A5 (enExample)
JP2012510502A5 (enExample)
JP2005513123A5 (enExample)
WO2002038553A3 (en) Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
RU2011152891A (ru) Диарилгидантоины
JP2005112864A5 (enExample)
JP2005525291A5 (enExample)
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
JP2006521359A5 (enExample)
RU2006137272A (ru) Производные 2-фенилпропионовой кислоты и содержащие их фармацевтические композиции
JP2007519721A5 (enExample)
JP2004517813A5 (enExample)
JP2007510662A5 (enExample)
JP2008546770A5 (enExample)
JP2005525392A5 (enExample)
JP2007519618A5 (enExample)